Header Logo

Connection

John Frazer to Precursor Cell Lymphoblastic Leukemia-Lymphoma

This is a "connection" page, showing publications John Frazer has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
  1. Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia. JAMA Oncol. 2021 Oct 01; 7(10):1521-1528.
    View in: PubMed
    Score: 0.189
  2. Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish. J Vis Exp. 2019 02 22; (144).
    View in: PubMed
    Score: 0.158
  3. UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo. Mol Cancer Ther. 2013 Nov; 12(11):2367-77.
    View in: PubMed
    Score: 0.108
  4. VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia. Leukemia. 2014 Jan; 28(1):216-20.
    View in: PubMed
    Score: 0.107
  5. Unexpected cytogenetic finding in acute lymphoblastic leukemia: a case of del(5q) with a cryptic t(12;21). Cancer Genet Cytogenet. 2006 Jul 15; 168(2):177-8.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.